Qu'apportent les nouvelles recommandations américaines à propos de la prise en charge des dyslipidémies en prévention cardiovasculaire ? Comparaison avec les recommandations européennes et belges

Descamps, Olivier S.;Rietzschel, Ernst R.;Langlois, Michel;Radermecker, Regis;De Backer, Guy;et.al.
(2014) Louvain médical — Vol. 133, n° 1, p. 26-35 (2014)

Files

2014_Descamps_Louvain_Médical.pdf
  • Restricted Access
  • Adobe PDF
  • 249.15 KB

Details

Authors
  • Descamps, Olivier S.
    Author
  • Rietzschel, Ernst R.
    Author
  • Langlois, Michel
    Author
  • Radermecker, Regis
    Author
  • De Backer, Guy
    Author
Show more
Abstract
(en) [What are the provisions in the new American recommendations regarding the management of dyslipidemia in cardiovascular prevention? Comparison with the European and Belgian recommendations] The latest American recommendations on dyslipidemia management in cardiovascular prevention have raised several questions, due to inherent differences with our standard approaches. Among others, these new recommendations have eradicated the need for a LDL-choiesterol 'target' depending on the level of cardiovascular risk. Instead, they have proposed a strategy based on the extent of the relative reduction in LDL-choiesterol. Critical review of European and American recommendations reveals, however, more similarities than differences. Comparing these recommendations Invites us to rethink several aspects of our clinical practice while enhancing our motivation to the greatest benefit of our patients.
Affiliations
  • Société belge d'Athérosclérose / Belgian Lipid Club

Citations

Descamps, O. S., Rietzschel, E. R., Langlois, M., Radermecker, R., Scheen, A. J., Ducobu, J., Hermans, A., Carpentier, Y., & De Backer, G. (2014). Qu’apportent les nouvelles recommandations américaines à propos de la prise en charge des dyslipidémies en prévention cardiovasculaire ? Comparaison avec les recommandations européennes et belges. Louvain médical, 133(1), 26-35. (Original work published 2014)